A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
Written informed consent is obtained prior to any procedures that are not consid... [+7]
For Part 2: has clear cell, mucinous or sarcomatous histology, mixed tumors cont... [+8]